• November 3, 2022

    – Clinical stage biopharmaceutical company completes upsized, [...]

  • June 24, 2022

    Paragon and its portfolio companies continue to [...]

  • May 25, 2022

    – Funding expected to provide sufficient capital [...]

  • April 5, 2022

    Expansion builds on initial strategic collaboration and [...]

  • March 1, 2022

    License agreement secures potential research of ecopipam for [...]